# Consensus vs RapidAI

Consensus records 6,014,388 monthly visits with -1.2% month-over-month growth and Freemium pricing. RapidAI records 20,172 monthly visits with -27.9% growth and Contact for Pricing pricing.

| Metric | [Consensus](https://openaitools.app/tool/consensus) | [RapidAI](https://openaitools.app/tool/rapidai-com) |
| :--- | :--- | :--- |
| Website URL | https://consensus.app | https://rapidai.com |
| Categories | AI Search Engine, AI Research Tool, AI Papers, AI Article Summarizer | AI Medical Diagnosis, AI Healthcare, AI Detector, AI Image Recognition |
| Pricing Model | Freemium | Contact for Pricing |
| Monthly Visits | 6,014,388 | 20,172 |
| MoM Growth Rate | -1.2% | -27.9% |
| Primary Market | United States | United States |
| Direct Visits | 2,918,713 | 9,047 |
| Review Score | 4.7 | 4.6 |
| Saved Count | 31 | 0 |
| Supported Platforms | Website | Website |

## Consensus

Consensus works like a scholarly search engine supercharged by AI. Instead of returning a flat list of PDFs, you ask a natural-language research question and Consensus extracts claims from relevant papers, then shows you what the studies actually find. A Consensus Meter summarizes the weight of evidence for yes/no questions, so you can see at a glance whether scientists largely agree, disagree, or remain divided.

The platform indexes hundreds of millions of peer-reviewed papers spanning medicine, biology, psychology, economics and more. Answers link straight back to the source studies, and you can filter by study design, journal quality, sample size and publication year to separate stronger evidence from weaker signals. Features like Deep Search, Topic Synthesis and Skills let researchers build a working knowledge base over time rather than starting from scratch on every query.

Consensus is designed for researchers, clinicians, students and analysts who need trustworthy signals from the scientific record without drowning in irrelevant results. A free tier gives limited AI-powered searches each month, while paid plans unlock unlimited use, advanced filters and deeper synthesis.

**Pricing & Plans:** Freemium. A free tier offers a limited number of AI-powered searches per month; paid individual plans unlock unlimited searches and advanced research features, with discounted student pricing and team/enterprise options.

- **Evidence-grounded answers:** Ask a research question in plain language and get answers synthesized from peer-reviewed studies, with each claim linked to its source paper.
- **Consensus Meter:** A visual summary shows how the scientific literature leans on a yes/no question, indicating agreement, disagreement or mixed evidence.
- **Powerful filters:** Narrow results by study design, sample size, journal quality, publication year and more to prioritize high-quality evidence.
- **Topic synthesis and Deep Search:** Aggregate findings across many studies into structured summaries that map what is known and where the gaps are.
- **Research workspace:** Save papers, organize sources and build a persistent knowledge base for literature reviews and ongoing projects.

**Strengths:** Answers cite real peer-reviewed papers, so claims are verifiable; Consensus Meter makes it easy to gauge scientific agreement at a glance; Rich filters help separate high-quality evidence from weaker studies; Fast, clean interface designed around research workflows

**Limitations:** Free tier caps the number of AI-assisted searches per month; Coverage is strongest for STEM and health fields, lighter for some humanities topics; It guides you toward sources but is not a substitute for reading full papers

[Profile (Markdown)](https://openaitools.app/tool/consensus.md)

## RapidAI

RapidAI grew out of stroke imaging research and has become one of the most widely deployed clinical AI platforms in healthcare. Its core promise is speed: when a large vessel occlusion or aneurysm is present, minutes matter, and RapidAI automatically detects, quantifies and communicates those findings to the treating team so decisions can be made sooner. Beyond neuro, the platform spans cardiac and vascular, trauma and emergency, oncology and radiology support workflows, all delivered through a single enterprise layer.

The Rapid Enterprise platform is built for scale rather than single-department pilots. It combines deep clinical AI with workflow integration, secure enterprise infrastructure, analytics dashboards and the ability to plug in partner AI models. That means a health system can standardize on one vendor-agnostic platform, connect imaging to action across service lines, and give administrators the visibility they need to track utilization and impact.

Adoption is aimed squarely at organizations, not individuals. Hospitals and radiology groups typically start with a demo request, then go through implementation and clinician education via RapidU before running the tools in production. The company reports FDA-cleared solutions, use in more than 2,500 hospitals globally and a publication library of over 750 peer-reviewed studies supporting its algorithms.

**Pricing & Plans:** Pricing is custom and quote-based; RapidAI does not publish a public price list. Interested organizations request a demo and discuss solution scope and licensing directly with the sales team.

- **Deep clinical AI across the body:** Detection and quantification algorithms for ischemic stroke, aneurysm, neurocritical care, aortic and pulmonary conditions, fractures, critical chest findings and lung, breast and prostate oncology.
- **Workflow integration:** Connect radiology, specialists and care teams with shared imaging insights so results reach the right clinician faster.
- **Enterprise infrastructure:** Vendor-agnostic, enterprise-grade infrastructure with healthcare-grade security and compliance that scales across a health system.
- **Data and analytics:** Visibility into utilization, performance and clinical impact so administrators can measure and optimize outcomes.
- **Integrated partner AI:** Access trusted third-party clinical AI models through the Rapid Enterprise platform alongside RapidAI's own solutions.

**Strengths:** Broad portfolio of FDA-cleared clinical AI algorithms in one platform; Designed for enterprise-wide deployment instead of isolated pilots; Strong validation base with 750+ peer-reviewed studies; Vendor-agnostic integration and 24/7 support

**Limitations:** Enterprise sales model with no self-serve signup or public pricing; Clinicians must complete training before using the tools in live care settings; Requires integration with existing PACS/IT infrastructure for full value; Only relevant to healthcare organizations; no consumer or individual use

[Profile (Markdown)](https://openaitools.app/tool/rapidai-com.md)

## Frequently Asked Questions

### How do Consensus and RapidAI compare in monthly traffic?

Consensus has 6,014,388 monthly visits, while RapidAI has 20,172. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Consensus has a month-over-month growth rate of -1.2%; RapidAI has -27.9%.

### How does pricing compare?

Consensus: Freemium. Freemium. A free tier offers a limited number of AI-powered searches per month; paid individual plans unlock unlimited searches and advanced research features, with discounted student pricing and team/enterprise options. RapidAI: Contact for Pricing. Pricing is custom and quote-based; RapidAI does not publish a public price list. Interested organizations request a demo and discuss solution scope and licensing directly with the sales team.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Perplexity](https://openaitools.app/tool/perplexity-ai) | 88,310,223 | -3.7% | Freemium | Covers general web sources alongside academic papers, but lacks specialized scientific synthesis metrics and consensus ratings. | [.md](https://openaitools.app/tool/perplexity-ai.md) |
| 2 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | Completely free access to a massive scholarly index, but offers less automated natural-language evidence synthesis than Consensus. | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 3 | [Kagi Search](https://openaitools.app/tool/kagi-search) | 4,647,605 | +3.2% | Free Trial, Paid | A paid, ad-free search engine that answers to its users | [.md](https://openaitools.app/tool/kagi-search.md) |
| 4 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | Provides deeper PDF reading and interactive literature analysis tools, but is less focused on quick evidence aggregation. | [.md](https://openaitools.app/tool/scispace.md) |
| 5 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | Performs advanced systematic review data extraction and evidence synthesis, but has a more complex interface than Consensus. | [.md](https://openaitools.app/tool/elicit.md) |
| 6 | [Jenni](https://openaitools.app/tool/jenni) | 1,498,133 | +5.2% | Freemium | The AI workspace where researchers read, write, and cite with every claim traceable to its source | [.md](https://openaitools.app/tool/jenni.md) |
| 7 | [Rayyan](https://openaitools.app/tool/rayyan) | 1,116,437 | +7.9% | Freemium | AI-assisted systematic review software for screening, extraction, and evidence synthesis at scale | [.md](https://openaitools.app/tool/rayyan.md) |
| 8 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | Tracks how papers are cited with Smart Citations to gauge reliability, but features a less direct Q&A synthesis. | [.md](https://openaitools.app/tool/scite.md) |
| 9 | [ResearchRabbit](https://openaitools.app/tool/researchrabbit) | 831,571 | +3.1% | Free | Excellent for visual citation mapping and literature discovery, but lacks automated paper Q&A and evidence synthesis. | [.md](https://openaitools.app/tool/researchrabbit.md) |
| 10 | [Connected Papers](https://openaitools.app/tool/connected-papers) | 750,576 | +3.1% | Freemium | Visualizes research connections through interactive graphs for literature discovery, but does not provide direct Q&A synthesis. | [.md](https://openaitools.app/tool/connected-papers.md) |

---
Source: https://openaitools.app/compare/consensus-vs-rapidai-com

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
